SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44)

The summary for the SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.

	Federal Grant Title:	SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44)
	CFDA Number:	93.394
	CFDA Description:	Cancer Detection and Diagnosis Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-CA-11-002
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Feb 03, 2011
	Creation Date:	Feb 03, 2011
	Original Closing Date for Applications:	Apr 07, 2011
	Current Closing Date for Applications:	Apr 07, 2011
	Archive Date:	May 08, 2011
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$10,000,000
	Federal Grant Award Ceiling:	$1,000,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant

Small businesses

Additional Information on Eligibility

Information not provided

Grant Description

This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded by NIH SBIR Phase II awards. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices and in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics. The purpose of this FOA is to facilitate the transition of SBIR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between NIHs SBIR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and technologies. Consistent with the goals of this funding initiative and as required by the SF424 instructions for all Phase II SBIR applications, applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Bridge Award project period. It is expected that the level of this independent third-party funding will equal or exceed the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required..

Link to Full Grant Announcement

http://grants.nih.gov/grants/guide/rfa-files/rfa-ca-11-002.html

Grant Announcement Contact

NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]

Similar Government Grants

• Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)

• Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01)

• Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01)

• Opportunity RFA-AI-10-030

• Image-Guided Cancer Interventions (STTR [R41/R42])

• An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44)

• IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS

• Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis

• PHASED APPLICATION AWARDS IN CANCER PROGNOSIS AND PREDICTION